Conclusion: Concurrent chemoradiotherapy with low-dose cisplatin regimen had a locoregional complete response rate after 6 months similar to that of high-dose cisplatin regimen, but with significantly lower rates of severe acute complications as well as higher completion rates. It is going to be the potential standard of treatment of locally advanced head and neck cancer in the future.